Intervention

Mesenchymal Stem Cell Transplantation

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions4

Lead sponsors shown1

Clinical trials

2 shown

Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by AnthracyclinesNCT02962661 · 2020-07-18

Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by AnthracyclinesNCT02408432 · 2016-01-11

Common conditions

Cardiomyopathy2 Heart Failure2 Hematopoietic and Lymphoid Cell Neoplasm1 Malignant Solid Neoplasm1

Leading sponsors

M.D. Anderson Cancer Center2

Trial status mix

COMPLETED1

SUSPENDED1

Phase mix

PHASE12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.